Table 4.
Underlying diseases for proven and probable cases of invasive aspergillosis (IA) without transplantation or primary immunosuppression
| underlying diseases/therapy | proven + probable IA n = 81 |
total (all proven and probable cases) (%) |
|---|---|---|
| tumor diseases | 10 | 12.3% |
| colorectal cancer (colectomy, rectal resection) | 4 | 4.9% |
| gastric cancer (gastrectomy) | 2 | 2.5% |
| cholangiocarcinoma (tumor resection) | 1 | 1.2% |
| hepatocellular carcinoma | 2 | 2.5% |
| renal carcinoma (nephrectomy) | 1 | 1.2% |
| other diseases | 26 | 32.5% |
| gastroenterologic diseases | 10 | 12.3% |
| necrotizing enterocolitis | 1 | 1.2% |
| necrotizing pancreatitis | 2 | 2.5% |
| chronical hepatitis B infection | 3 | 3.7% |
| liver cirrhosis | 3 | 3.7% |
| citrullinaemia | 1 | 1.2% |
| prematurity | 1 | 1.2% |
| heart diseases | 4 | 4.9% |
| congenital heart disease | 1 | 1.2% |
| dilatative cardiomyopathy | 2 | 2.5% |
| endocarditis | 1 | 1.2% |
| vascular diseases | 1 | 1.2% |
| type B dissection (stent implantation) | 1 | 1.2% |
| renal diseases | 4 | 6.2% |
| renal insufficiency | 4 | 4.9% |
| other diseases | 5 | 6.2% |
| multiple trauma | 3 | 3.7% |
| sinusitis maxillaris | 2 | 2.5% |